Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Cost-effectiveness analysis of the tislelizumab versus do... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Cost-effectiveness analysis of the tislelizumab versus docetaxel for advanced or metastatic non-small-cell lung cancer in China
0
Authors
Qian Zhang
7 more
Qian Zhang
•
Xiongxiong Fan
5 more
•
Dong Liu
Published
July 18, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Public Health
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Cancer
Show all topics
DOI
10.3389/fpubh.2024.1425734
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Public Health
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Cancer
Show all topics
DOI
10.3389/fpubh.2024.1425734
License
CC-BY
Other Formats
PDF
